FindTrial
Sign In

Phase 2 higher-dose study of S-888711 in thrombocytopenic patients with chronic liver disease

Phase 2 higher-dose study of S-888711 in thrombocytopenic patients with chronic liver disease

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221585
Enrollment
Unknown
Registered
2011-09-15
Start date
2011-09-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thrombocytopenic patients with chronic liver disease

Interventions

investigational material(s) Generic name etc : S-888711 INN of investigational material : Therapeutic category code : 339 Other agents relating to blood and body fluides Dosage and Administration for

Sponsors

SHIONOGI & CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Thrombocytopenic patients with chronic liver disease undergoing percutaneous ablation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
safety, efficacy—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026